Cited by 51Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorTryptophan and brain disorders

Effect of theanine on norepinephrine and serotonin levels in rat brain

Open access
KIMURA, RYOHEI, MURATA, TOSHIRO·1986·Chemical and Pharmaceutical Bulletin

Abstract

The effects of i.p. administered theanine (L-N-ethylglutamine), a constituent of Japanese green tea, on the levels of norepinephrine (NE) and serotonin (5-HT) in the brain of rats with or without coadministration of caffeine were investigated, and compared with those of glutamine.Theanine decreased the NE level, whereas no change was observed with glutamine or caffeine.The decrease of NE induced by theanine was reversed by caffeine. In rats pretreated with pargline, a monoamine oxidase inhibitor, theanine significantly increased the NE level compared with the control. However, it did not enhance the NE levels increased by caffeine. Thus, theanine may decrease the NE levels by releasing this neurotransmitter.Theanine did not alter the levels of 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) in rats pretreated with or without pargyline, indicating that this amide affects neither 5-HT synthesis nor its degradation. Caffeine increased the levels of 5-HT and 5-HIAA in normal rats to similar extents.This effect was depressed by theanine. In rats pretreated with pargyline, the levels of 5-HT and 5-HIAA were not altered by caffeine, and theanine did not modify the outcome. It may be concluded that the action of theanine is related to the possible inhibition of 5-HT release by caffeine. The effect of glutamine on the levels of 5-HT was somewhat different form that of theanine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1248/cpb.34.3053

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Modulation of the monoamine and glutamic acid and glycine systems may also contribute to the four weeks psychotropic effects of L-theanine.

    “The modulation of the monoamine [14,15,16,17] and glutamic acid and glycine [18,19] systems may also contribute to these four weeks psychotropic effects.”

    From Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial (2019) · cites this paper as [17]

    The Results (p. 2) show that theanine changed norepinephrine levels in rat brain, supporting the monoamine-modulation part attributed to this source. The study measured acute neurochemical effects, not whether monoamine modulation contributes to psychotropic effects over four weeks. The glutamic-acid and glycine portion is assigned to other citations in the citing sentence. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. [1]This paper constitutes Part V of the series entitled "Influence of Alkylamides of Glutamic Acid and Related Compounds on the Central Nervous System," Part VI: R. Kimura and T. Murata, Chem. Pharm. Bull., 28, 664 (1980).
  2. [3]R. W. Butcher and E. W. Sutherland, J. Biol. Chem., 237, 1244 (1962). a) B. A. Berkowitz and S. Spector, Eur. J. Pharmacol., 16, 322 (1971); b) U. Stromberg and B. Waldeck, J. Neural Transm., 34, 241 (1973); c) G. Curzon and J. C. R. Fernando, Brit. J. Pharmacol., 58, 533 (1976); d) A. J. Schlosberg, J. D. Fernstom, M. C. Kopczynski, B. M. Cusack and M. A. Gills, Life Sci., 29, 173 (1981); e) A. J. Schlosberg, Arch. Int. Pharmacodyn. Ther., 267, 149 (1984); f) M. H. Fernstrom, C. W. Bazil and J. D. Fernstrom, Life Sci., 35, 1241 (1984). a) B. Waldeck, J. Pharm. Pharmacol., 23, 824 (1971); b) Idem, Psychopharmacologia, 36, 209 (1974); c) H. Corrodi, K. Fuxe and G. Jonsson, J. Pharm. Pharmacol., 24, 155 (1972).
  3. [6]Y. Sakato, Nippon Nogeikagaku Kaishi, 23, 262 (1950).
  4. [8]R. Kimura, M. Kurita and T. Murata, Yakugaku Zasshi, 95, 892 (1975). a) R. Kimura and T. Murata, Chem. Pharm. Bull., 19, 1257 (1971); b) Idem, ibid., 19, 1301 (1971).
  5. [9]T. Furuyama, T. Yamashita and S. Senoh, Bull. Chem. Soc. Jpn., 37, 1078 (1964).
  6. [11]R. H. Cox and J. L. Perhach, J. Neurochem., 20, 1777 (1973).
  7. [12]C. C. Chang, Int. J. Neuropharmacol., 3, 643 (1964).
  8. [14]R. P. Maickel, R. H. Cox, J. Saillant and F. P. Miller, Int. J. Neuropharmacol., 7, 275 (1968).
  9. [13]G. B. Ansell and M. F. Beeson, Anal. Biochem., 23, 196 (1968).
  10. [15]N. H. Yessaian, A. R. Armenian and H. Ch. Buniatian, J. Neurochem., 16, 1425 (1969).
  11. [17]L. Valzelli and S. Bernasconi, Pharmacol. Biochem. Behav., 1, 251 (1973).
  12. [16]B. A. Berkowitz, J. H. Tarver and S. Spector, Eur. J. Pharmacol., 10, 64 (1970).

Cited by

Sorted by citations

Authors
KIMURA, R., & MURATA, T.
Venue
Chemical and Pharmaceutical Bulletin
Published
1986
Volume
34
Issue
7
Pages
3053-3057
ISSN
  • 0009-2363 (ISSN-L)
  • 1347-5223
OpenAlex
W1974559875
Cited by
51
References
2
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 2 · 2012: 2
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Chemical and Pharmaceutical Bulletin (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
theanine, norepinephrine, serotonin, 5-hydroxyindoleacetic acid, caffeine, glutamine, pargyline, monoamine oxidase inhibition, neurotransmitter release, brain monoamines
MeSH terms
Animals, Brain Chemistry, Glutamates, Male, Norepinephrine, Rats, Inbred Strains, Serotonin, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review